戻る Agenda
Session 28: Audits and Inspections, Part 2
Session Chair(s)
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
This session will extend the concepts for GCP inspections covered in Session 17 to the post-marketing experience in pharmacovigilance. Several case studies will be discussed.